Posted in | Nanobusiness

Nanostart-Held BioMicro Systems Appoints New President and COO

Nanostart-held BioMicro Systems announces the appointment of Rob Parry as President and Chief Operating Officer. Mr. Parry will be focused on expanding sales of the MAUI Microarray Product Suite, as well as launching a new line of products for the cytogenetics market. IGOR™, an "Automated Lab Assistant" for processing FISH, WISH, Blots and other slide-based applications, will be available Fall 2009.

BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary microfluidic and microarray technologies.

Mr. Parry has been serving as Chief Operating Officer and Vice President of Manufacturing at BioMicro Systems since February of 2007. Prior to BioMicro Systems, Mr. Parry held top level manufacturing positions in several instrument and consumable businesses, including Hewlett Packard, Agilent Technologies, Fluidigm, and Nanosys. His innovative and effective leadership at BioMicro Systems has led to ISO 9001 certification of the organization, and cost-effective manufacturing processes with consistent high quality and availability of products. In addition to his manufacturing responsibilities at BioMicro, Mr. Parry directed product development efforts and is a co-inventor of both the new IGOR system as well as the successful new design of the MAUI Wash System.

Mr. Parry added, "I am excited to take the lead of the BioMicro Systems team. I see great near term opportunities for our new products and applications. The IGOR system will be the Company's first medical device sold into the clinical market, introducing the Company to a whole new customer base."

Mr. Parry received a B.S.M.E. from Cal Poly, San Luis Obispo, and an M.S. from MIT in Operations Management and Technology Innovation.

About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit

About BioMicro Systems, Inc.:
BioMicro Systems, Inc. is a private company focused on the development and commercialization of biological research products based on its proprietary microfluidic and microarray technologies. More company information can be found at

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback